Skip to Main Content

Paper Details

The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study.
Front Public Health
6
2022
Author NameAffiliation
Hasan M Al-DorziKing Abdullah International Medical Research Center-King Saud Bin Abdulaziz University for Health Sciences
Hasan M Al-DorziKing Abdulaziz Medical City
Hasan M Al-DorziCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences
  • 1 - 3

Datasets

Release 1.2